SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department-Reference-Cited by-同舟云学术

SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department

Published:2021-02-18 Issue:3 Volume:26 Page:213-220
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Möckel Martin¹^ORCID,Corman Victor M.²³^ORCID,Stegemann Miriam S.⁴^ORCID,Hofmann Jörg²⁵,Stein Angela⁵,Jones Terry C.²^ORCID,Gastmeier Petra⁶,Seybold Joachim⁷,Offermann Ralf¹,Bachmann Ulrike¹,Lindner Tobias¹,Bauer Wolfgang⁸,Drosten Christian²,Rosen Alexander⁹,Somasundaram Rajan⁸

Affiliation:

1. Department of Emergency and Acute Medicine, Campus Mitte and Virchow, Charité – Universitätsmedizin Berlin, Berlin, Germany

2. Institute of Virology, Charité – Universitätsmedizin Berlin, Berlin, Germany

3. German Centre for Infection Research (DZIF), Charité – Universitätsmedizin Berlin, Berlin, Germany

4. Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany

5. Labor Berlin – Charité Vivantes GmbH, Charité – Universitätsmedizin Berlin, Berlin, Germany

6. Institute for Hygiene and Environmental Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany

7. Medical Directorate, Charité – Universitätsmedizin Berlin, Berlin, Germany

8. Department of Emergency and Acute Medicine, Campus Benjamin Franklin, Charité – Universitätsmedizin Berlin, Berlin, Germany

9. Department of Pediatrics, Division of Pulmonology Immunology and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Berlin, Germany

Funder

German Federal Ministry of Education and Research through projects VARIPath

NaFoUniMedCovid19

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2021.1876769

Reference11 articles.

1. Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

2. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples

3. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

4. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

5. Corman, V. M. et al., 2020b. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests. medRxiv,

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is BMI Associated with COVID-19 Severity? A Retrospective Observational Study;Current Medicinal Chemistry;2023-12

2. Diagnostic performance of rapid antigen tests for SARS-CoV-2 transmission risk based on cycle threshold values in the emergency department;The American Journal of Emergency Medicine;2023-12

3. Immunological tests: Essential and supportive tools in the fight against COVID-19;TrAC Trends in Analytical Chemistry;2023-11

4. Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences;Molecular Biology Reports;2023-10-10

5. Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study;European Journal of Medical Research;2023-09-02